Drug repurposing reveals Posaconazole as a CYP11A1 inhibitor enhancing anti-tumour immunity
Jhuma Pramanik, Sanu Korumadathil Shaji, Megan Zaman, Bethany Brown, Baojie Zhang, Yumi Yamashita-Kanemaru, Natalie Z M Homer, Hosni A. M. Hussein, Qiuchen Zhao, Klaus Okkenhaug, Rahul Roychoudhuri, Abhik Mukhopadhyay, Bidesh Mahata
The paper identifies Posaconazole as a CYP11A1 inhibitor that enhances anti-tumour immunity in a mouse model of lung metastasis.
iScience · Apr 18, 2025Peer-reviewedImmunology